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Background: Cryptocarya-derived crude extracts and their compounds have been reported to have an antiproliferation
effect on several types of cancers but their impact on oral cancer is less well understood.
Methods: We examined the cell proliferation effect and mechanism of C. concinna-derived cryptocaryone (CPC) on oral
cancer cells in terms of cell viability, apoptosis, reactive oxygen species (ROS), mitochondrial depolarization, and DNA
damage.
Results: We found that CPC dose-responsively reduced cell viability of two types of oral cancer cells (Ca9-22 and CAL
27) in MTS assay. The CPC-induced dose-responsive apoptosis effects on Ca9-22 cells were confirmed by flow cytometry-
based sub-G1 accumulation, annexin V staining, and pancaspase analyses. For oral cancer Ca9-22 cells, CPC also induced
oxidative stress responses in terms of ROS generation and mitochondrial depolarization. Moreover, γH2AX flow cytometry
showed DNA damage in CPC-treated Ca9-22 cells. CPC-induced cell responses in terms of cell viability, apoptosis,
oxidative stress, and DNA damage were rescued by N-acetylcysteine pretreatment, suggesting that oxidative
stress plays an important role in CPC-induced death of oral cancer cells.
Conclusions: CPC is a potential ROS-mediated natural product for anti-oral cancer therapy.
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Oral cancer is the sixth most common cancer in the
world [1, 2]. Oral cancer is easy to detect clinically but is
frequently ignored by patients resulting in high mortality
rates [3]. Although several oral tumor markers have
been reported [4, 5], these efforts focused on detection
rather than therapy and effective anti-oral cancer therap-
ies are still needed.
Cryptocarya (family Lauraceae) is widely found in the
tropics and subtropics [6]. Its crude extracts have been* Correspondence: miyihu@gmail.com; changhw@kmu.edu.tw
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cancer. For example, methanolic extracts of the leaves of
C. griffithiana and the roots of C. concinna can inhibit
cell proliferation of human HL60 promyelocytic
leukemia cells [7] and oral cancer cells [8], respectively.
The ethanolic extracts of the fruit and trunk bark of C.
obovata have been reported to have an antiproliferative
effect against human KB cells [9].
Several Cryptocarya-derived compounds have been
found to have diverse biological functions, i.e., anti-
dengue virus by alkylated flavanones [10], anti-HIV by
phenanthroindolizidine alkaloids [11], anti-tuberculosis by
pinocembrin [12], anti-plasmodial by (+)-N-methylisoco-
claurine, atherosperminine, and 2-hydroxy-atherosperminine
[13], anti-trypanosomal by 7′,8′-dihydroobolactone [14], andis distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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tocaryanone B [15].
Recently, Cryptocarya-derived compounds have been
reported to have an antiproliferation effect on cancer.
For example, the proliferation of leukemia cells was
inhbitied by C. costata-derived 2′,4′-dihydroxy-5′,6′-
dimethoxychalcone and isodidymocarpin [16] and C.
konishii-derived by desmethylinfectocaryone, infecto-
caryone, and cryptocaryone (CPC) [17]. Among these
Cryptocarya-derived compounds, we are interested in
the anticancer effect of CPC, which is one of the major
constituents in the commonly distributed evergreen
plant C. concinna in Taiwan [18].
Although the anticancer effect of CPC, a kind of dihy-
drochalcone, had been reported in some cancer types
such as murine leukemia [17] and prostate cancer [19],
few studies have addressed its antiproliferative effect on
oral cancer. Moreover, the cell killing mechanism of
cryptocaryone in cancer remains unclear. Recently, re-
active oxygen species (ROS) generation was reported to
be involved in Corema album-derived dihydrochalcone
induced cytotoxicity for colon cancer cells [20]. Accord-
ingly, the relationship between ROS generation and CPC
effect for oral cancer cells is worth examining.
This study evaluates possible anticancer functions of
CPC and explores its drug mechanisms in terms of cell
viability, cell cycle analysis, apoptosis, ROS generation,
mitochondrial depolarization, and DNA damage detec-
tion. The role of oxidative stress in CPC’s effect on oral
cancer cells is also addressed.
Methods
Plant material and isolation
C. concinna was identified by one of the authors (Ih-Sheng
Chen) and its roots were collected at Mudan, Pingtung
County, Taiwan, in May 2004. A voucher specimen
(Chen6153) has been deposited in the Herbarium of the
School of Pharmacy, College of Pharmacy, Kaohsiung
Medical University. The dried roots (7.7 Kg) of C. con-
cinna were processed by slicing and cold methanol-
extraction three times at room temperature. Finally, the
solution was evaporated under reduced pressure to yield
the methanolic extract (800 g; yield: methanolic extract/
dried roots = 10.4 %) [8]. CPC (5.7 g; yield: CPC/methano-
lic extract = 0.7 %) was isolated from the root of C. con-
cinna as described previously [19]. In brief, the methanolic
extract was partitioned between chloroform/water (1:1) to
yield a chloroform fraction and a water fraction. The
chloroform fraction was subjected to silica gel column
chromatography and eluted with a gradient of chloro-
form–methanol to produce 13 fractions (A-1–A-13). CPC
was then obtained from fraction A-3 (chloroform-metha-
nol 100:1) and the structure of CPC was determined by
spectral analyses (Additional file 1).Cell cultures and chemicals
Two human oral cancer cell lines (Ca9-22 [21] and CAL
27 [22]), purchased from the Cell Bank, RIKEN BioRe-
source Center (Tsukuba, Japan) and the American Type
Culture Collection (ATCC; Virginia, USA), respectively,
were incubated in DMEM/F12 (3:2) medium (Gibco,
Grand Island, NY, USA) supplemented with 10 % fetal
bovine serum (Gibco), 100 U/ml penicillin, 100 μg/ml
streptomycin, and 0.03 % glutamine. Normal gingival
fibroblast (HGF-1) was purchased from ATCC and
maintained in DMEM medium (Gibco, Grand Island,
NY, USA) with a similar supplement with 1 mM pyru-
vate as described above. Cells were incubated in humidi-
fied air at 37 °C with 5 % CO2. N-acetylcystein (NAC)
was purchased from Sigma (St. Louis, MO, USA) for
pretreatment before CPC application. Passage numbers
of the oral cancer (Ca9-22 and CAL 27) cells used in this
study were 15–22 and 8–15, respectively.
Cell viability
Cell viability was determined using the CellTiter 96®
AQueous One Solution Cell Proliferation Assay (MTS)
(Promega Corporation, Madison,WI, USA) as previously
described [21]. Two oral cancer cell lines (Ca9-22 and
CAL 27) were seeded at 1 × 105 cells per well and HGF-
1 cells were seeded at 4 × 104 cells per well in a 6-well
plate, respectively. After seeding for 24 h, cells were
treated with CPC at indicated concentrations for 24 h
and cell viability was determined by an ELISA reader at
490 nm.
Determination of cell cycle distribution
Propidium iodide (PI) (Sigma, St Louis, MO, USA) was
added to stain the cellular DNA content [23]. In brief,
3 × 105 cells per well in 6 well plates were seeded over-
night and then treated with the vehicle (0.05 % DMSO)
or 3, 6, 9, 12 μM of CPC for 24 h. After cells were har-
vested and washed twice with PBS, they were fixed
overnight with 70 % ethanol. Subsequently, the cell
pellets were resuspended in 50 μg/ml PI for 30 min at
37 °C in darkness. The cell cycle distribution was eval-
uated by a flow cytometer (BD Accuri™ C6; Becton-
Dickinson, Mansfield, MA, USA) and BD Accuri™ C6
software (version 1.0.264).
Determination of apoptosis by annexin V/PI
Apoptosis was detected by annexin V (Strong Biotect
Corporation, Taipei, Taiwan)/PI (Sigma, St Louis, MO,
USA) as described in [24]. Briefly, 3 × 105 cells per well
in 6 well plates were seeded for 24 h and then treated
with the vehicle or indicated concentrations of CPC for
24 h. Cells were then incubated with 100 μl binding
buffer containing 2 μl of annexin-V-fluorescein isothio-
cyanate (FITC) stock (0.25 μg/μl) and 2 μl of PI stock
Fig. 1 Cell viabilities of CPC-treated oral cancer cells and the effect
of NAC pretreatment. Oral cancer (Ca9-22 and CAL 27) cells and
oral normal (HGF-1) cells were chosen. With or without 2 mM NAC
pretreatment for 1 h, Ca9-22 and HGF-1 cells were treated with 3,
6, 9, and 12 μM of CPC and CAL 27 cells were treated with 2, 4, 6,
and 8 μM of CPC for 24 h incubation. The cell viability was measured by
the MTS assay. Data, means ± SDs (n= 6). For the same drug treatment
of different concentrations, data marks (a to d) without overlapping by
the same lower-case letter significantly differed (one-way ANOVA with
Tukey HSD Post Hoc Test)
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400 μl PBS for flow cytometry analysis (BD Accuri™ C6;
Becton-Dickinson).
Determination of apoptosis by pancaspase activity
The apoptosis was also detected by the measurement of
caspase activation [25]. In this study, the generic activation
of pancaspases (Caspase-1, 3, 4, 5, 6, 7, 8, 9) was deter-
mined by the generic caspase activity assay kit (Abcam,
Cambridge, UK) as described in [26]. Briefly, Ca9-22 cells
were seeded as 3 × 105 cells per well in 6 well plates with
2 ml medium. The next day, Ca9-22 cells were treated
with CPC for 24 h, 2 μl of 500X TF2-VAD-FMK was then
added, and the cells were incubated at 37 °C, 5 % CO2 for
2 h. Cells were washed with PBS twice and resuspended in
0.5 ml of assay buffer for immediate flow cytometry meas-
urement (BD Accuri™ C6; Becton-Dickinson).
Determination of intracellular ROS
The dye 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-
DA) was used to detect ROS by its fluorescence change
[27]. Cells at the density of 3 × 105 in 2 ml medium per well
in 6 well plates were seeded for 24 h. Different concentra-
tions of CPC were added to Ca9-22 cells for 3 h. After
washing with PBS, 100 nM DCFH-DA in PBS were added
to the cells in 6 well plates in a cell culture incubator for
30 min. After trypsinization, PBS washing, and centrifuga-
tion, cell pellets were resuspended in 1 ml PBS before flow
cytometry analysis (BD Accuri™ C6; Becton-Dickinson) and
its software.
Determination of mitochondrial membrane potential
(MitoMP)
MitoProbe™ DiOC2(3) assay kit (Invitrogen, Eugene, OR,
USA) was applied to analyze MitoMP as described previ-
ously [28, 29]. Briefly, 3 × 105 cells in 2 ml medium per
well in 6 well plates were seeded for 24 h. After CPC treat-
ment, 10 μl of 10 μM DiOC2(3) was added per well and
incubated in a cell culture incubator for 30 min. After har-
vesting, cells were resuspended in 1 ml PBS for flow cy-
tometry analysis (BD Accuri™ C6; Becton-Dickinson).
Determination of DNA damage by γH2AX/PI
DNA double strand breaks were detected by flow cytome-
try as described previously [30]. In brief, CPC-treated cells
were fixed in 70 % ethanol, washed with BSA-T-PBS solu-
tion (1 % bovine serum albumin and 0.2 % Triton X-100 in
PBS; Sigma), and incubated at 4 °C for 1 h in 100 μl of
BSA-T-PBS solution containing 0.2 μg p-Histone H2A.X
(Ser 139) monoclonal antibody (Santa Cruz Biotechnology,
Santa Cruz, CA, USA). Cells were washed and suspended
for 1 h in a 1:50 dilution of Alexa Fluor 488-tagged second-
ary antibody (Jackson Laboratory, Bar Harbor, ME, USA)
for staining for 30 min at room temperature. Finally, thecells were resuspended in 20 μg/ml of PI for flow cytome-
try analysis (BD Accuri™ C6; Becton-Dickinson).
Statistical analysis
Group differences of the same drug treatment with differ-
ent concentrations were analyzed by one-way ANOVA
with Tukey HSD Post Hoc Test using JMP® 10 software
[21]. No overlapping by the same lower-case letter indi-
cated significant differences.
Results
Assessment of antiproliferation of CPC and the effect of
NAC pretreatment
In the MTS assay (Fig. 1), the cell viability (%) of two
oral cancer cells (Ca9-22 and CAL 27) at indicated con-
centrations of CPC were dose-responsively decreased
(P < 0.05–0.001 compared to the vehicle). In contrast,
the cell viabilities of oral normal HGF-1 cells were
similar to the control at 3 and 6 μM of CPC although
cell viability decreased at 9 and 12 μM. The IC50 values
of CPC for oral cancer Ca9-22 and CAL 27 cells were
9.87 and 3.45 μM, respectively, whereas IC50 was un-
detected in the CPC-treated oral normal HGF-1 cells
under the same CPC treatment.
NAC, an ROS scavenger, is commonly used to validate
the role of oxidative stress in drug-induced ROS-
mediated effects [31–34]. NAC pretreatment was per-
formed to examine the possible role of oxidative stress
in CPC-induced cell death, showing that the CPC-
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cells were almost completely rescued compared to con-
trols (Fig. 1).
Assessment of sub-G1 accumulation of CPC and the effect
of NAC pretreatment
The distribution profiles of CPC-induced cell cycle
changes of oral cancer Ca9-22 cells are shown in
Fig. 2a (top). After CPC treatment (Fig. 2b), the sub-
G1 populations of CPC (0–12 μM)-treated Ca9-22
cells were dose-responsively increased (P < 0.001). In
contrast, the G0/G1 and G2/M populations of CPC-
treated Ca9-22 cells were almost dose-responsively de-
creased (P < 0.001).
The distribution profiles of NAC pretreatment effect
against CPC-induced cell cycle changes are shown in
Fig. 2a (bottom). After NAC pretreatment, i.e., NAC +
CPC (Fig. 2b, right), the CPC-induced cell cycle
changes as mentioned above recovered to normal dis-
tributions compared to CPC only (Fig. 2b, left) and un-
treated controls.
Assessment of annexin V/PI-based apoptosis of CPC and
the effect of NAC pretreatment
To further validate the role of apoptosis, the annexin V/PI
profiles of CPC-treated oral cancer Ca9-22 cells wereFig. 2 The sub-G1 accumulations of CPC-treated oral cancer Ca9-22 cells
pretreatment for 1 h, Ca9-22 cells were treated with 0, 3, 6, 9, and 12 μM
distribution profiles of CPC-treated Ca9-22 cells. The cell cycle phases are
percentages in Fig. 2a. Data, mean ± SD (n = 3). For the same drug treatment
the same lower-case letter significantly differed (one-way ANOVA with Tukeydemonstrated by flow cytometry (Fig. 3a, top). In Fig. 3b,
the populations of annexin V-positive intensities for CPC
(0–12 μM)-treated Ca9-22 cells were dose-responsively
increased (P < 0.05–0.001).
The annexin V/PI profiles of NAC pretreatment effect
against CPC-induced apoptosis were also demonstrated
in Fig. 3a (bottom). After NAC pretreatment, i.e., NAC
+ CPC (Fig. 3b), the CPC-induced apoptosis changes as
mentioned above recovered to normal levels compared
to CPC only and untreated controls.Assessment of pancaspase-based apoptosis of CPC and
the effect of NAC pretreatment
To further validate the role of apoptosis, the pancaspase
profiles of CPC-treated oral cancer Ca9-22 cells were
demonstrated by flow cytometry (Fig. 4a, top). In Fig. 4b,
the populations of pancaspase-positive intensities for CPC
(0–12 μM)-treated Ca9-22 cells were dose-responsively
increased (P < 0.001).
The pancaspase profiles of NAC pretreatment effect
against CPC-induced apoptosis were also demonstrated in
Fig. 4a (bottom). After NAC pretreatment, i.e., NAC +
CPC (Fig. 4b), the CPC-induced apoptosis changes as men-
tioned above recovered to normal levels compared to CPC
only and untreated controls.and the effect of NAC pretreatment. With or without 2 mM NAC
of CPC for 24 h. a Representative flow cytometry-based cell cycle
underlined in each panel. b Quantification analysis for the subG1
of different concentrations, data marks (a to d) without overlapping by
HSD Post Hoc Test)
Fig. 3 Annexin V/PI-based apoptosis of CPC-treated oral cancer Ca9-22 cells and the effect of NAC pretreatment. With or without 2 mM NAC
pretreatment for 1 h, Ca9-22 cells were treated with 0, 3, 6, 9, and 12 μM of CPC for 24 h. a Representative results of flow cytometry-based
annexin V/PI double staining of CPC-treated Ca9-22 cells. Annexin V (+)/PI (+) and Annexin V (+)/PI (-) were calculated as the apoptosis (+) in
each panel. b Quantification analysis of apoptosis for CPC-treated Ca9-22 cells in Fig. 3a. Data, mean ± SD (n = 3). For the same drug treatment of
different concentrations, data marks (a and b) without overlapping by the same lower-case letter significantly differed (one-way ANOVA with
Tukey HSD Post Hoc Test)
Fig. 4 Generic caspase-based apoptosis of CPC-treated oral cancer Ca9-22 cells and the effect of NAC pretreatment. a With or without 2 mM
NAC pretreatment for 1 h, Ca9-22 cells treated with 0, 3, 6, 9, and 12 μM of CPC for 24 h were stained with 1 μl 500X TF2-VAD-FMK. The right side
indicates the pancaspase (Pan) positive region in each panel. b Quantificative analysis of pan-caspase fluorescent intensity. Data, mean ± SD (n = 3). For
the same drug treatment of different concentrations, data marks (a to e) without overlapping by the same lower-case letter significantly differed
(one-way ANOVA with Tukey HSD Post Hoc Test)
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NAC pretreatment
Accumulated evidence showed that ROS-generating drugs
and natural products may lead to apoptosis [35–38]. To
validate the role of ROS in the CPC induced cell death
effect, an ROS staining dye (DCFH-DA) was applied to
flow cytometry. Figure 5a shows the ROS staining profiles
of CPC-treated Ca9-22 cells at 3 h incubation. After
CPC treatment, the relative ROS-positive staining of
CPC (0–12 μM)-treated Ca9-22 cells were dose-
responsively induced (P < 0.001) (Fig. 5b).
The ROS staining profiles of NAC pretreatment effects
against CPC-induced ROS generation were also demon-
strated in Fig. 5a (bottom). After NAC pretreatment, i.e.,
NAC + CPC (Fig. 5b), the CPC-induced ROS changes as
mentioned above recovered to normal levels compared
to CPC only and untreated controls.Assessment of MitoMP of CPC and the effect of NAC
pretreatment
To validate the role of MitoMP in the CPC-induced ef-
fects, a mitochondrial membrane potential-sensitive
staining dye (DiOC2(3)) was applied to flow cytometry.
Figure 6a shows the MitoMP staining profiles of CPC-
treated Ca9-22 cells at 24 h incubation. After CPC
treatment, the relative MitoMP-positive staining ofFig. 5 ROS generation of CPC-treated oral cancer Ca9-22 cells and the effe
1 h, Ca9-22 cells were treated with 0, 3, 6, 9, and 12 μM of CPC for 6 and 1
Ca9-22 cells. The right side indicates the ROS positive region in each panel
mean ± SD (n = 3). For the same drug treatment of different concentrations
significantly differed (one-way ANOVA with Tukey HSD Post Hoc Test)CPC (0–12 μM)-treated Ca9-22 cells were dose-
responsively decreased (P < 0.001) (Fig. 6b).
The MitoMP staining profiles of NAC pretreatment ef-
fects against CPC-induced ROS generation were also
demonstrated in Fig. 6a (bottom). After NAC pretreat-
ment, i.e., NAC + CPC (Fig. 6b), the CPC-induced
MitoMP changes as mentioned above recovered to near
normal levels compared to CPC only and untreated
controls.Assessment of γH2AX/PI-based DNA damage of CPC and
the effect of NAC pretreatment
To further examine the role of DNA damage in CPC-
induced effects, the DNA double strand break (DSB)
marker (γH2AX) was chosen for use in flow cytometry.
Figure 7a displays the γH2AX/PI staining profiles of
CPC-treated Ca9-22 cells at 24 h incubation. After
CPC treatment, the γH2AX-positive staining of CPC
(0–12 μM)-treated Ca9-22 cells were dose-responsively
decreased (P < 0.001) (Fig. 7b).
The γH2AX staining profiles of NAC pretreatment ef-
fect against CPC-induced DNA damage were also demon-
strated in Fig. 7a (bottom). After NAC pretreatment, i.e.,
NAC +CPC (Fig. 7b), the CPC-induced γH2AX changes
as mentioned above recovered to near normal levels com-
pared to CPC only and untreated controls.ct of NAC pretreatment. With or without 2 mM NAC pretreatment for
2 h. a Representative ROS profiles of flow cytometry for CPC treated
. b Quantification analysis of relative ROS intensity in Fig. 5a. Data,
, data marks (a to e) without overlapping by the same lower-case letter
Fig. 6 Depolarization of mitochondrial membrane potential (MitoMP) of CPC-treated oral cancer Ca9-22 cells and the effect of NAC pretreatment.
With or without 2 mM NAC pretreatment for 1 h, Ca9-22 cells were treated with 0, 3, 6, 9, and 12 μM of CPC for 24 h. a Representative MitoMP
profiles of flow cytometry for CPC treated Ca9-22 cells. The right side indicates the MitoMP positive region in each panel. b Quantification analysis
of relative MitoMP intensity in Fig. 6a. Data, mean ± SD (n = 3). For the same drug treatment of different concentrations, data marks (a to d)
without overlapping by the same lower-case letter significantly differed (one-way ANOVA with Tukey HSD Post Hoc Test)
Fig. 7 γH2AX-based DNA damage in CPC-treated oral cancer Ca9-22 cells and the effect of NAC pretreatment. With or without 2 mM NAC
pretreatment for 1 h, cells were treated with 0, 3, 6, 9, and 12 μM of CPC for 24 h. a Representative flow cytometry-based DSB profile for
CPC-treated Ca9-22 cells. Dashed lines indicate the γH2AX positive regions in each panel. b Quantification analysis of fold changes in γH2AX-
based DNA damage in CPC-treated Ca9-22 cells. Data, mean ± SD (n = 3). For the same drug treatment of different concentrations, data marks
(a to e) without overlapping by the same lower-case letter significantly differed (one-way ANOVA with Tukey HSD Post Hoc Test)
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Fig. 8 Schematic diagram of hypothesized mechanism of CPC-induced
cell killing of human oral cancer cells. Changes in oral cancer cells
(Ca9-22) are indicated by bold arrows, such as increases of oxidative
stress, apoptosis, DNA damage, and cell death. The upward arrows
indicate the increase in each assay of this study. Different assays were
shown in parentheses. The bold arrow with “?” symbol is not examined
in this study
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Cryptocarya-derived compounds were identified has hav-
ing diverse biological functions including antiproliferation
for several types of cancer. However, its effect on oral can-
cer cells has been less-well addressed. The current study
examines the possible anti-oral cancer effect of C. con-
cinna-derived CPC and explores drug response mechan-
ism in detail.
Selective killing of CPC
Several anti-oral cancer drugs have harmful side effects
for normal cells, thus limiting their clinical applications,
and anticancer therapies ideally should have selective
cell killing effects [21, 37]. In current study, we found
that CPC were cytotoxic to two oral cancer cells but less
harmful to oral normal cells (Fig. 1). Accordingly, CPC
has the potential for selective killing to oral cancer cells.
Comparison of drug sensitivity of CPC
Cryptocaryone has recently been reported to inhibit pro-
liferation of prostate cancer cells where its IC50 value is
1.6 to 3.4 μM 48 h by SRB assay [19]. C. konishii-dervied
cryptocaryone was found to inhibit proliferation of mur-
ine leukemia P-388 cells where its IC50 value is 0.04 μM
48 h by MTT assay [17]. Cryptocaryone was also re-
ported to be an active compound for antiproliferation in
the KB cell lines with IC50 values 1.8 μM at 3 days by
MTT assay [39]. However, KB cells were recently found
to be human cervical cancer HeLa cells rather than oral
epidermal carcinoma [40]. Accordingly, the anti-oral
cancer effects of cryptocaryone are still largely unknown.
In the present study, we firstly found that CPC had an
antiproliferative effect against oral cancer cells and the
IC50 values of CPC in oral cancer Ca9-22 and CAL 27
cells at 24 h by MTS assay were 11.63 and 3.91 μg/ml,
respectively.
The role of apoptosis in CPC studies
The current study provides evidence for the apoptosis ef-
fect of CPC in oral cancer Ca9-22 cells, such as subG1 ac-
cumulation, annexin V/PI staining, and pancaspase
analyses (Figs. 2, 3 and 4). Gene expression of apoptotic
and anti-apoptotic proteins may be further validated by
western blot or by PCR. For example, we found that apop-
totic protein poly (ADP-ribose) polymerase (PARPγ) [41]
of Ca9-22 cells and anti-apoptotic protein BCL2 [42] of
CAL 27 cells was respectively up- and down-regulated
after CPC treatments (data not shown). In future, work re-
lated to p53, p21, p27 and phospho p53 will be of more
additional value to further find the detailed effect of CPC
on apoptotic pathway. Similarly, cryptocaryone also re-
portedly induced apoptosis in human prostate cancer PC3
cells in terms of the subG1 accumulation, cleavage of
caspase-8 and 3, death receptor DR5 accumulation onmembranes, and up-regulation of Mcl-1 expression [19].
However, the role of oxidative stress of CPC-treated PC3
cells is not addressed. Instead, we had discussed the
involvement of oxidative stress in CPC-treated oral cancer
cells in next section.
The role of oxidative stress in dihydrochalcone studies
CPC is a kind of dihydrochalcone that is shown to kill oral
cancer cells (Fig. 1). Similarly, Muntingia calabura-derived
dihydrochalcones (2′,4′-dihydroxy-3′-methoxydihydrochal-
cone and (-)-3′-methoxy-2′,4′,beta-trihydroxydihydrochal-
cone) have been reported to be cytotoxic to murine
leukemia P-388 cells and human colon cancer HT-29 cells
[43]. Corema album-derived dihydrochalcones (2′,4′-dihy-
droxydihydrochalcone and 2′-methoxy-4′-hydroxydihydro-
chalcone) have been reported to be cytotoxic to colon
cancer HT-29 cells [20] and their cell killing effects were
reduced by NAC pretreatment [20], Consistently, we found
that NAC pretreatment can inhibit CPC-induced ROS
generation (Fig. 5) and mitochondrial depolarization (Fig. 6).
Moreover, we also found that the CPC-induced subG1
accumulation, apoptosis (annexin V and caspase activities),
and DNA damage were rescued by NAC pretreatment
(Figs. 2, 3, 4 and 7). These findings suggest that oxidative
stress may be involved in the cytotoxic activity of these
dihydrochalcones. Moreover, oxidative stress may induce
autophagy and apoptosis [44]. In future, it warrants for
modulating autophagy and apoptosis by inhibitors such as
3-methyladenine/chloroquine [45] and Z-VAD-FMK [46]
to investigate their individual contributions on CPC-
induced antiproliferation of oral cancer cells.
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responses. For example, neohesperidin dihydrochalcone, a
non-nutritive sweetening agent produced by hydrogen-
ation of neohesperidin, displayed antioxidant properties to
inhibit hypochlorous acid-induced DNA damage and cell
death [47] and to inhibit carbon tetrachloride-induced
oxidative damage both in vivo and in vitro [48]. Therefore,
the functions of dihydrochalcones may have dual roles
and may be dependent on its chemical properties, i.e.,
ROS generation or scavenging.
Conclusion
In conclusion, we demonstrate that CPC can inhibit cell
proliferation and apoptosis of oral cancer cells but is less
harmful to normal oral cells. This cell killing mechanism
includes the ROS generation, mitochondrial depolarization,
and DNA damage, which can be rescued by NAC pretreat-
ment. Therefore, these results suggest that CPC has an an-
ticancer potential for oxidative stress-mediated oral cancer
therapy based on the cell line study (Fig. 8). In future,
in vivo methods to explore the in vivo mechanism will pro-
vide concrete evidence of CPC.
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